MARFIA, GIROLAMA ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 47.592
EU - Europa 10.482
AS - Asia 8.317
SA - Sud America 1.045
AF - Africa 94
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 18
Totale 67.567
Nazione #
US - Stati Uniti d'America 47.345
IT - Italia 5.987
SG - Singapore 4.022
CN - Cina 1.210
BR - Brasile 874
RU - Federazione Russa 839
HK - Hong Kong 743
KR - Corea 677
DE - Germania 665
IE - Irlanda 606
VN - Vietnam 567
UA - Ucraina 539
FR - Francia 433
BD - Bangladesh 358
GB - Regno Unito 354
JP - Giappone 233
NL - Olanda 224
SE - Svezia 220
FI - Finlandia 198
CA - Canada 138
IN - India 135
PL - Polonia 111
AT - Austria 60
AR - Argentina 58
MX - Messico 55
CH - Svizzera 49
TR - Turchia 46
IQ - Iraq 45
ES - Italia 39
ID - Indonesia 39
ZA - Sudafrica 35
BE - Belgio 29
RO - Romania 28
CL - Cile 26
MY - Malesia 26
EC - Ecuador 25
IR - Iran 23
PH - Filippine 23
PK - Pakistan 22
UZ - Uzbekistan 22
SA - Arabia Saudita 21
CO - Colombia 17
AU - Australia 16
EG - Egitto 16
CZ - Repubblica Ceca 15
GR - Grecia 14
MA - Marocco 14
PY - Paraguay 14
AE - Emirati Arabi Uniti 12
EU - Europa 12
KG - Kirghizistan 12
VE - Venezuela 11
AZ - Azerbaigian 10
HR - Croazia 10
LT - Lituania 10
NP - Nepal 10
PE - Perù 10
AL - Albania 9
JM - Giamaica 9
NO - Norvegia 9
TH - Thailandia 9
TT - Trinidad e Tobago 9
KE - Kenya 8
UY - Uruguay 8
DZ - Algeria 7
SV - El Salvador 6
TW - Taiwan 6
A2 - ???statistics.table.value.countryCode.A2??? 5
DO - Repubblica Dominicana 5
HN - Honduras 5
IL - Israele 5
JO - Giordania 5
TN - Tunisia 5
BB - Barbados 4
BG - Bulgaria 4
DK - Danimarca 4
LB - Libano 4
LU - Lussemburgo 4
OM - Oman 4
QA - Qatar 4
SK - Slovacchia (Repubblica Slovacca) 4
BH - Bahrain 3
BS - Bahamas 3
GE - Georgia 3
LV - Lettonia 3
NG - Nigeria 3
PR - Porto Rico 3
PT - Portogallo 3
RS - Serbia 3
SI - Slovenia 3
AM - Armenia 2
AO - Angola 2
BO - Bolivia 2
CY - Cipro 2
ET - Etiopia 2
GT - Guatemala 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
MM - Myanmar 2
NI - Nicaragua 2
Totale 67.541
Città #
Wilmington 12.528
Houston 11.475
Woodbridge 11.457
Singapore 1.734
Fairfield 1.149
San Jose 910
Chandler 859
Ashburn 800
Ann Arbor 797
Hong Kong 729
Rome 679
Dublin 554
Milan 493
Seattle 457
New York 448
Cambridge 429
Beijing 423
Medford 373
Jacksonville 365
Dearborn 318
Santa Clara 312
The Dalles 230
Los Angeles 217
Council Bluffs 189
Ho Chi Minh City 189
Tokyo 187
Lawrence 176
Dallas 173
Buffalo 154
Lauterbourg 148
Moscow 144
Bologna 142
Hanoi 132
Naples 109
Turin 109
São Paulo 90
Torino 81
Zhengzhou 81
Verona 80
San Diego 77
Florence 70
Kraków 67
North Bergen 67
Helsinki 61
Creede 53
London 51
Redondo Beach 51
Nuremberg 49
Padova 48
Redwood City 48
Chicago 47
Orem 47
Munich 44
Norwalk 44
Mülheim 43
Menlo Park 42
Trento 41
Frankfurt am Main 40
Palermo 40
Genoa 39
Atlanta 37
Brescia 36
Palo Alto 35
Piove di Sacco 35
Roebling 35
Bari 34
Lappeenranta 32
Seoul 32
Toronto 32
Montreal 30
Pavia 30
Cagliari 27
Warsaw 27
Jakarta 26
Amsterdam 25
Bergamo 25
Brussels 25
Salt Lake City 25
Shanghai 25
Brooklyn 24
Boardman 23
Phoenix 23
San Francisco 23
Stockholm 23
Vienna 23
Belo Horizonte 22
Guangzhou 22
Haiphong 22
Nanjing 22
Catania 21
Chennai 21
Da Nang 21
Mcallen 21
Monza 21
Elk Grove Village 20
Hefei 20
Ottawa 20
Parma 20
Pescara 20
Rimini 20
Totale 52.014
Nome #
Batteria per la valutazione del Deterioramento Mentale (parte II): standardizzazione e affidabilità diagnostica nell’identificazione di pazienti affetti da sindrome demenziale 2.543
Batteria per la valutazione del Deterioramento Mentale (parte I): descrizione di uno strumento di diagnosi neuropsicologica 2.509
Batteria per la valutazione del Deterioramento Mentale (parte III): analisi dei profili qualitativi di compromissione cognitiva 1.033
The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. 735
The impact of rotigotine on cardiovascular autonomic function in early Parkinson's disease 603
Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy 574
Neurophysiology of synaptic functioning in multiple sclerosis 573
Posterior cortical atrophy with unilateral occipito-temporal degeneration 561
Explicit memory and repetition priming in dementia: evidence for a common basic mechanism underlying conscious and unconscious retrieval deficits 556
Electrophysiology of sipatrigine: a lamotrigine derivative exhibiting neuroprotective effects 551
A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication 528
No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML 515
Lexical and conceptual components of stem completion priming in patients with Alzheimer's disease 512
Common polymorphisms in MIR146a, MIR128a and MIR27a genes contribute to neuropathy susceptibility in type 2 diabetes 510
Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis 510
Chronic dopaminergic treatment in restless legs syndrome: Does it affect the autonomic nervous system? 507
TRPV1 polymorphisms and risk of interferon β-induced flu-like syndrome in patients with relapsing-remitting multiple sclerosis 506
Brain MR diffusion tensor imaging in Kennedy's disease 498
Subacute demyelinating polyneuropathy in B-cell lymphoma with IgM antibodies against glycolipid GD1b 497
Anti-sulfatide/galactocerebroside antibodies in immunoglobulin M paraproteinemic neuropathies 493
Association of HLA-DQB1∗05:02 and DRB1∗16 Alleles with Late-Onset,Nonthymomatous, AChR-Ab-Positive Myasthenia Gravis 491
Abnormal cervical lymph nodes in multiple sclerosis: a preliminary ultrasound study 485
Percutaneous tibial nerve stimulation produces effects on brain activity: study on the modifications of the long latency somatosensory evoked potentials 475
Synaptic transmission in the striatum: from plasticity to neurodegeneration 468
Heart rate variability is differentially altered in multiple sclerosis: implications for acute, worsening and progressive disability 467
Acute disseminated encephalomyelitis following Campylobacter jejuni gastroenteritis: Case report and review of the literature 464
RANTES correlates with inflammatory activity and synaptic excitability in multiple sclerosis 463
Central and peripheral nervous system involvement as a manifestation of graft versus host disease after liver transplantation: case report 459
International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome 455
Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study 453
IgM MGUS and Waldenstrom-associated anti-MAG neuropathies display similar response to rituximab therapy 452
Sympathetic autonomic system is differentially altered in progressive and relapsing multiple sclerosis 451
Interleukin-8 is associated with acute and persistent dysfunction after optic neuritis 448
Fingolimod reduces the clinical expression of active demyelinating lesions in MS 445
Acute demyelinating sensorimotor polyneuropathy in B-cell lymphoma with IGM autoantibodies against glycolipid GD1B 443
Inverse correlation between VEGF and soluble VEGF receptor 2 in POEMS with AIDP responsive to intravenous immunoglobulin 439
Perceptual and conceptual components in implicit and explicit stem completion 438
Intestinal pseudobstruction as presenting event of fatal cerivastatin-induced myopathy 438
Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: implications for ischemia and Huntington's disease 437
A multicentric cohort study on anti-mag antibodies neuropathy: does response to rituximab differ depending on the associated hematological disease? 437
Nerve growth factor is elevated in the CSF of patients with multiple sclerosis and central neuropathic pain 435
Italian multicentre study of peroneal mononeuropathy: multiperspective follow-up 434
Electrophysiological recordings and calcium measurements in striatal large aspiny interneurons in response to combined O2/glucose deprivation 433
An in vitro electrophysiological study on the effects of phenytoin, lamotrigine and gabapentin on striatal neurons 432
Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing–remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study) 432
EPIDEMIOLOGY AND POTENTIAL PROGNOSTIC FACTORS IN GUILLAIN-BARRE SYNDROME: TEN-YEAR EXPERIENCE OF "POLICLINICO TOR VERGATA" 430
A Novel Association Between Nondipping and Painful Diabetic Polyneuropathy 427
IS DN4 AS A SCREENING TOOL FOR NEUROPATHIC PAIN SUITABLE FOR PAINFUL DIABETIC POLYNEUROPATHY? 427
Clinical correlates of painful diabetic neuropathy and relationship of neuropathic pain with sensorimotor and autonomic nerve function 425
Post-ischaemic long-term synaptic potentiation in the striatum: a putative mechanism for cell type-specific vulnerability 424
Validation of the nerve axon reflex for the assessment of small nerve fibre dysfunction 424
Bickerstaff encephalitis with anti gm1-antibodies relapsing as guillain-barre syndrome: a case report 424
Ionic mechanisms underlying differential vulnerability to ischemia in striatal neurons 423
INSULIN AUTOIMMUNE SYNDROME (HIRATA DISEASE) RELATED TO THE ALPHA-LIPOIC ACID ASSUMPTION: CASE REPORT AND REVIEW OF THE LITERATURE 419
The autonomic balance predicts cardiac responses after the first dose of fingolimod 418
Recency effect in anterograde amnesia: evidence for distinct memory stores underlying enhanced retrieval of terminal items in immediate and delayed recall paradigms 415
Diabetic peripheral neuropathic pain is a stronger predictor of depression than other diabetic complications and comorbidities 415
Repetitive transcranial magnetic stimulation of the motor cortex ameliorates spasticity in multiple sclerosis 414
Heidenhain variant in two patients with inherited V210I Creutzfeldt-Jakob disease 412
Bickerstaff encephalitis: report of two atypical cases with negative anti GQ1B antibodies 409
Frequency-modulated electromagnetic neural stimulation (FREMS) as a treatment for symptomatic diabetic neuropathy: results from a double-blind, randomised, multicentre, long-term, placebo-controlled clinical trial 406
Sensory profiles of neuropathic pain in painful diabetic polyneuropathy 401
Sensory profiles of neuropathic pain in painful diabetic polyneuropathy 400
Prevalence and characteristics of neuropathic pain in painful diabetic polyneuropathy 400
Is autonomic nervous system involved in restless legs syndrome during wakefulness? 399
Glutamate-triggered events inducing corticostriatal long-term depression 398
Activation of metabotropic glutamate receptor subtype 1/protein kinase C/mitogen-activated protein kinase pathway is required for postischemic long-term potentiation in the striatum 396
Long latency somatosensory evoked potentials: Modifications after percutaneous tibial nerve stimulation 396
Is autonomic nervous system involved in restless legs syndrome during wakefulness? 395
Il deterioramento cognitivo nel paziente cerebroleso 392
Electrophysiology of the neuroprotective agent riluzole on striatal spiny neurons 391
Subclinical autonomic dysfunction in spinobulbar muscular atrophy (Kennedy disease) 389
High sensitivity of autonomic function tests in a case of food-borne botulism 389
Does continuous positive airway pressure treatment affect autonomic nervous system in patients with severe obstructive sleep apnea? 389
Neuropathic pain impact on sleep and circadian rhythm of blood pressure in painful diabetic polyneuropathy 387
The neuroprotective agent BW619C89 inhibits neuronal excitability and synaptic transmission in rat corticostriatal slices 386
Autonomic nervous system involvement in patients with chronic dysimmune neuropathies 381
Meningomyeloradiculitis mimicking recurrent bilateral neuralgic amyotrophy. 378
A multicentric cohort study on anti-mag antibodies neuropathy: does response to rituximab differ depending on the associated hematological disease? 378
Validity of the Italian multiple sclerosis neuropsychological screening questionnaire 374
Tissue plasminogen activator controls multiple forms of synaptic plasticity and memory 372
Pharmacological inhibition of the Na(+)/Ca(2+) exchanger enhances depolarizations induced by oxygen/glucose deprivation but not responses to excitatory amino acids in rat striatal neurons 371
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course 366
Neuropatie disimmuni 364
Validity of DN4 as a screening tool for neuropathic pain of painful diabetic polyneuropathy 364
AN ITALIAN MULTICENTER DATABASE FOR THE DIAGNOSIS AND THERAPY OF CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY (CIDP) AND ITS VARIANTS: DATA FROM THE FIRST 300 PATIENTS 364
Efficacy of intravenous immunoglobulin in poems-related relapsing AIDP 363
Remodeling functional connectivity in multiple sclerosis: A challenging therapeutic approach 363
Il priming di ripetizione nel deterioramento cognitivo: ipotesi sull’organizzazione della funzione mnesica 362
Modulation of gene expression following long-term synaptic depression in the striatum 359
Glutamate-triggered events inducing corticostriatal LTD 359
Effects of motor cortex rTMS on lower urinary tract dysfunction in multiple sclerosis 358
Relapsing aidp responsive to intravenous immunoglobulin in poems syndrome 357
Corticobulbar And Corticospinal Tract Involvement In Kennedy's Disease 356
Myotonic dystrophy unlinked to DM1 and DM2 mutations in three siblings 354
High dose intravenous immunoglobulin is effective in painful diabetic polyneuropathy resistant to conventional treatments: results of a double blind, randomized, placebo-controlled, multicenter trial 351
Long latency somatosensory evoked potentials: Changes after percutaneous tibial nerve stimulation 348
Dimethyl fumarate vs. fingolimod in multiple sclerosis: an independent, multi-centre, real world, quasi-randomized study 347
Nondipping is a novel associated disorder of painful diabetic polyneuropathy 346
Prevalence of anti-neurofascin-155 and anti-contactin-1 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: a serological multicenter study in Italy 344
Totale 47.887
Categoria #
all - tutte 173.314
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 173.314


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021130 0 0 0 0 0 0 0 0 0 0 0 130
2021/20222.205 142 164 118 187 145 209 132 131 146 183 131 517
2022/20233.352 266 183 299 380 241 610 419 220 278 90 257 109
2023/20241.764 178 62 125 165 142 221 142 127 107 117 89 289
2024/20256.612 228 1.094 631 414 240 486 438 260 630 608 844 739
2025/202610.007 734 458 1.078 642 925 329 1.346 1.115 1.190 876 706 608
Totale 68.565